|
| | 17-PHENYL TRINOR PROSTAGLANDIN E2 Basic information |
| Product Name: | 17-PHENYL TRINOR PROSTAGLANDIN E2 | | Synonyms: | 17-PHENYL-TRINOR-PROSTAGLANDIN E2 98%;17-PHENYL TRINOR PROSTAGLANDIN E2 99+%;17-Phenyl-18,19,20-trinor-PGE2;17-Phenyl-18,19,20-trinorprostaglandin E2;17-Phenyl-omega-trinor-PGE2;17-PHENYL TRINOR PROSTAGLANDIN E2;9-OXO-11ALPHA-15S-DIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z,13E-DIEN-1-OIC ACID;17-Phenyltrinorprostaglandinee2 | | CAS: | 38315-43-4 | | MF: | C23H30O5 | | MW: | 386.48 | | EINECS: | | | Product Categories: | | | Mol File: | 38315-43-4.mol |  |
| | 17-PHENYL TRINOR PROSTAGLANDIN E2 Chemical Properties |
| Boiling point | 597.1±50.0 °C(Predicted) | | density | 1?+-.0.06 g/cm3(Predicted) | | RTECS | MJ9681060 | | solubility | DMF: >100 mg/ml (from Fluprostenol); DMSO: >100 mg/ml (from Fluprostenol); Ethanol: >100 mg/ml (from Fluprostenol); PBS pH 7.2: >0.8 mg/ml (from 17-phenyl tri | | pka | 4.75±0.10(Predicted) | | form | Oil |
| | 17-PHENYL TRINOR PROSTAGLANDIN E2 Usage And Synthesis |
| Uses | 17-Phenyl-trinor-prostaglandin E2 is a synthetic analog of PGE2 and an agonist at the EP1 and EP3 receptor (1). Prostaglandin E2(PGE2) regulates neuroinflammatory responses and is upregulated in brain injury by cyclooxygenase 2 (COX-?2) and membrane-bound PGE synthase. 17-Phenyl-trinor-prostaglandin E2 can be used to investigate inflammatory signaling pathways (2). | | Definition | ChEBI: 17-phenyl-18,19,20-trinor-prostaglandin E2 is a prostanoid that is 18,19,20-trinor-prostaglandin E2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group. It has a role as a human metabolite and a prostaglandin receptor agonist. It is a prostanoid, an alicyclic ketone, a beta-hydroxy ketone, a secondary alcohol, an oxo monocarboxylic acid, a hydroxy monocarboxylic acid and an olefinic compound. |
| | 17-PHENYL TRINOR PROSTAGLANDIN E2 Preparation Products And Raw materials |
|
